, decrease Baht 0.59 million or 6.08%, both period not very difference. 2. Cost of sale , Profit margin In Q3/2017 the company had cost of sale Baht 85.71 million compare with the same period of previous year
comparison million or net profit o Summary The Operatin venues : Revenues from services Other income Total rev penses : Cost of sales an Administrative expenses Total ex are of profit o associated com nance
quarter of 2019 Second quarter of 2018 Increased (Decreased) Amount % 1.1 Revenues from construction Baht 1,353.08 million Baht 2,199.81 million Baht 846.73 million (38.49) 1.2 Cost of construction 102.44
: Income Statement Unit : Thousand Baht Performance (Income Statement) Q1.2018 Q1.2017 Increased/ (Decreased) % Income Sales 46,822 43,021 3,801 8.84 Services income 27,672 - 27,672 100.00 Cost of sales
, 2018 with details as follow; unit: million baht Items 6-month period ended 2017 6-month period ended 2018 changes Amount % Amount % Amount % Revenue from sales of goods . . . . . . Cost of sales of goods
Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549
, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
Residence Freehold and Leasehold Property Fund 3 12 (9) (75) 14 28 (14) (50) Total 311 469 (158) (34) 742 925 (183) (20) III Cost of sales breakdown by business segment (Unit: Million Baht) Second quarter 6
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
equipment for lease 80.9 80.6 55.2 0.3 0.4 25.7 46.6 Cost of sales and service 1,348.2 953.9 1,366.0 394.3 41.3 (17.8) (1.3) Cost of equipment for lease 44.2 42.6 31.3 1.6 3.8 12.9 41.2 Administrative